248 related articles for article (PubMed ID: 24859482)
1. Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells.
Ma J; Han LZ; Liang H; Mi C; Shi H; Lee JJ; Jin X
Oncol Rep; 2014 Jul; 32(1):235-42. PubMed ID: 24859482
[TBL] [Abstract][Full Text] [Related]
2. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.
Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X
Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213
[TBL] [Abstract][Full Text] [Related]
3. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.
Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X
J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244
[TBL] [Abstract][Full Text] [Related]
4. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
[TBL] [Abstract][Full Text] [Related]
5. Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis.
Han X; Sun S; Zhao M; Cheng X; Chen G; Lin S; Guan Y; Yu X
PLoS One; 2014; 9(11):e112470. PubMed ID: 25383959
[TBL] [Abstract][Full Text] [Related]
6. Dihydrotanshinone I inhibits the translational expression of hypoxia-inducible factor-1α.
Li J; Mi C; Ma J; Wang KS; Lee JJ; Jin X
Chem Biol Interact; 2015 Oct; 240():48-58. PubMed ID: 26282490
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma.
Liu LP; Ho RL; Chen GG; Lai PB
Clin Cancer Res; 2012 Oct; 18(20):5662-71. PubMed ID: 22929805
[TBL] [Abstract][Full Text] [Related]
8. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
García-Maceira P; Mateo J
Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
[TBL] [Abstract][Full Text] [Related]
9. Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways.
Ma J; Li J; Wang KS; Mi C; Piao LX; Xu GH; Li X; Lee JJ; Jin X
Int Immunopharmacol; 2016 Oct; 39():1-9. PubMed ID: 27394002
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells.
Zhang Q; Tang X; Lu QY; Zhang ZF; Brown J; Le AD
Mol Cancer Ther; 2005 Oct; 4(10):1465-74. PubMed ID: 16227395
[TBL] [Abstract][Full Text] [Related]
11. Vanillic Acid Suppresses HIF-1α Expression via Inhibition of mTOR/p70S6K/4E-BP1 and Raf/MEK/ERK Pathways in Human Colon Cancer HCT116 Cells.
Gong J; Zhou S; Yang S
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678221
[TBL] [Abstract][Full Text] [Related]
12. Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells.
Weng Q; Zhang J; Cao J; Xia Q; Wang D; Hu Y; Sheng R; Wu H; Zhu D; Zhu H; He Q; Yang B
Invest New Drugs; 2011 Dec; 29(6):1177-87. PubMed ID: 20524035
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1α pathway.
Huang L; Zhang Z; Zhang S; Ren J; Zhang R; Zeng H; Li Q; Wu G
Int J Mol Med; 2011 Mar; 27(3):407-15. PubMed ID: 21249310
[TBL] [Abstract][Full Text] [Related]
14. 4′,6-dihydroxy-4-methoxyisoaurone inhibits the HIF-1α pathway through inhibition of Akt/mTOR/p70S6K/4E-BP1 phosphorylation.
Mi C; Ma J; Shi H; Li J; Wang F; Lee JJ; Jin X
J Pharmacol Sci; 2014; 125(2):193-201. PubMed ID: 25075425
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.
Li G; Shan C; Liu L; Zhou T; Zhou J; Hu X; Chen Y; Cui H; Gao N
PLoS One; 2015; 10(2):e0117440. PubMed ID: 25659153
[TBL] [Abstract][Full Text] [Related]
16. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
[TBL] [Abstract][Full Text] [Related]
17. Tirapazamine sensitizes hepatocellular carcinoma cells to topoisomerase I inhibitors via cooperative modulation of hypoxia-inducible factor-1α.
Cai TY; Liu XW; Zhu H; Cao J; Zhang J; Ding L; Lou JS; He QJ; Yang B
Mol Cancer Ther; 2014 Mar; 13(3):630-42. PubMed ID: 24362462
[TBL] [Abstract][Full Text] [Related]
18. Dictamnine promotes apoptosis and inhibits epithelial-mesenchymal transition, migration, invasion and proliferation by downregulating the HIF-1α and Slug signaling pathways.
Wang JY; Wang Z; Li MY; Zhang Z; Mi C; Zuo HX; Xing Y; Wu YL; Lian LH; Xu GH; Piao LX; Ma J; Jin X
Chem Biol Interact; 2018 Dec; 296():134-144. PubMed ID: 30266538
[TBL] [Abstract][Full Text] [Related]
19. Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway.
Zhang J; Cao J; Weng Q; Wu R; Yan Y; Jing H; Zhu H; He Q; Yang B
PLoS One; 2010 Nov; 5(11):e13910. PubMed ID: 21085474
[TBL] [Abstract][Full Text] [Related]
20. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
